FOLD icon

Amicus Therapeutics

141 hedge funds and large institutions have $1.75B invested in Amicus Therapeutics in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

5% more funds holding

Funds holding: 134141 (+7)

3.61% more ownership

Funds ownership: 118.25%121.86% (+3.6%)

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

Holders
141
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$31.4M
Puts
$12.9M
Net Calls
Net Calls Change

Top Buyers

1 +$70.8M
2 +$30.2M
3 +$14.3M
4
Morgan Stanley
Morgan Stanley
New York
+$11.3M
5
TCP
Tourbillon Capital Partners
New York
+$11M

Top Sellers

1 -$11.4M
2 -$10.4M
3 -$10.3M
4
Axa
Axa
France
-$8.47M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$8.34M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$923K
77
$908K
78
$897K
79
$866K
80
$791K
81
$790K
82
$705K
83
$704K
84
$685K
85
$665K
86
$626K
87
$600K
88
$599K
89
$581K
90
$560K
91
$558K
92
$519K
93
$511K
94
$441K
95
$427K
96
$372K
97
$350K
98
$316K
99
$308K
100
$292K